Sjögren’s Syndrome: Dry Eyes, Dry Mouth, and the Systemic Disease Behind Them

Sjögren’s Syndrome is a chronic autoimmune disease where the immune system attacks the salivary and lacrimal glands, causing severe dryness of the mouth and eyes. However, Sjögren’s is much more than just a disease of dryness. The autoimmune process affects multiple organ systems throughout the body, making it a systemic disease with serious health implications. Sjögren’s Syndrome affects approximately one to three percent of the population worldwide, making it one of the most common autoimmune diseases. The disease predominantly affects women, with a female-to-male ratio of approximately nine to one. Sjögren’s most commonly develops in middle-aged and older women, though it can occur at any age. The disease was first described by Swedish ophthalmologist Henrik Sjögren in 1933, and the eponym has been retained in honor of his recognition of this condition. Sjögren’s Syndrome is caused by autoimmune antibodies attacking the exocrine glands that produce saliva and tears. The immune system produces antibodies against muscarinic-3 receptor, ribonucleoprotein A and B, and other autoantigens. These autoimmune antibodies cause inflammation and destruction of the glands. The inflammatory process destroys the gland-producing cells. Salivary gland destruction reduces saliva production. Lacrimal gland destruction reduces tear production. The loss of saliva and tears causes the characteristic symptoms of dryness. However, the autoimmune inflammation extends beyond the salivary and lacrimal glands. The immune system can attack virtually any organ system. Rheumatoid factor is positive in about sixty percent of Sjögren’s patients. Antinuclear antibodies are present in about fifty percent. Anti-Ro and anti-La antibodies are present in about fifty percent. These autoimmune antibodies indicate systemic autoimmune disease. Sjögren’s Syndrome is associated with increased risk of lymphoma. The chronic immune activation increases B cell lymphoma risk. Lung involvement, kidney involvement, nervous system involvement, and heart involvement can occur. The systemic nature of Sjögren’s means it can affect multiple organs causing serious complications. Understanding that Sjögren’s is systemic, not just a disease of dryness, helps with appropriate management and recognition of complications. Early diagnosis and appropriate systemic treatment can prevent or reduce complications. Understanding Sjögren’s helps with recognition of early signs and appropriate management.

How Does Autoimmune Attack on Glands Cause Sjögren’s Syndrome?

To understand Sjögren’s Syndrome, we need to learn about the salivary and lacrimal glands and how the immune system attacks them. The salivary glands produce saliva. Saliva contains enzymes that begin digestion. Saliva lubricates food for swallowing. Saliva lubricates the mouth. Saliva has antimicrobial properties protecting against infections. The lacrimal glands produce tears. Tears lubricate the eyes. Tears contain lysozyme, which has antimicrobial properties. Tears are necessary for clear vision. In Sjögren’s Syndrome, the immune system becomes abnormally activated against these glands. B cells produce autoimmune antibodies. T cells infiltrate the glands. The activated immune cells attack the gland tissue. Inflammation develops in the salivary glands. The glands become swollen and tender. Inflammatory cells release inflammatory cytokines. The inflammation damages gland cells. Acinar cells, the cells that produce saliva and tears, are destroyed. Lymphocytes infiltrate the gland tissue. Germinal centers form within the glands. The germinal centers are sites of B cell activation and antibody production. Progressive destruction of gland tissue occurs. As gland cells are destroyed, they cannot be replaced. The functional capacity of the glands decreases. Saliva production decreases. Tear production decreases. The loss of saliva and tears causes the characteristic dryness. The autoimmune response extends beyond the salivary and lacrimal glands. Lymphocytes can infiltrate other organs. The lungs, kidneys, nervous system, and other organs may be affected. The systemic inflammation is driven by persistent B cell and T cell activation. Autoimmune antibodies circulate in the blood. Anti-Ro and anti-La antibodies are present. These antibodies can deposit in tissues and activate complement. Immune complex deposition causes tissue damage. The inflammatory process is chronic and progressive. Without treatment, inflammation continues. Progressive destruction of glands. Progressive systemic inflammation. Organ damage accumulates. Early treatment suppresses the immune activation. Immunosuppressive therapy reduces inflammation. Reduces antibody production. Prevents progressive organ damage. Understanding the immune mechanisms has led to development of targeted treatments.

What Are the Main Symptoms and Signs of Sjögren’s Syndrome?

Sjögren’s Syndrome causes variable symptoms affecting the mouth, eyes, and potentially many other organ systems. The symptoms develop insidiously over months to years. Dry mouth, or xerostomia, is the hallmark symptom. Mouth feels dry. Difficulty swallowing dry food. Frequent sipping of water. Difficulty tasting food. Inability to speak for extended periods without drinking water. Mouth becomes very dry. Saliva is thick and ropy. Difficulty wearing dentures. Dry eyes, or xerophthalmia, is also very common. Eyes feel gritty. Sensation of sand in eyes. Foreign body sensation. Excessive tearing paradoxically occurs as the eyes respond to dryness. Eyes may be red. Sensitivity to light. Blurred vision. Difficulty reading or working on computers. Eye symptoms often worse in dry environments. Morning eye stickiness from mucus. Dental problems result from dry mouth. Dental caries accelerate. Tooth decay rapidly. Multiple cavities develop. Recurrent mouth sores develop. Mouth ulcers are painful. Mouth sores interfere with eating. Oral candidiasis, or thrush, develops more frequently. White patches in mouth. Oral pain. Fungal infections from reduced antimicrobial effect of saliva. Salivary gland swelling occurs. Enlargement of parotid glands. Swelling in front of ears. Jaw pain and discomfort. Difficulty eating. Salivary gland swelling can come and go. Systemic symptoms may develop. Fatigue is common. Profound exhaustion. Fatigue limits activity. Joint pain and arthritis develop in many. Hands and feet commonly affected. Joint swelling. Morning stiffness. Unlike rheumatoid arthritis, Sjögren’s arthritis does not cause permanent joint deformity. Fever may occur. Low-grade fever with flares. Chills with fever. Muscle pain may occur. Muscle weakness in some. Neurological symptoms can develop. Numbness and tingling. Peripheral neuropathy. Cognitive changes. Difficulty concentrating. Memory problems. Seizures rarely. Skin manifestations may develop. Raynaud’s phenomenon. Rashes including photosensitive rashes. Vaginal dryness occurs in women. Dryness of other mucous membranes. Sexual dysfunction. Lung involvement can cause. Shortness of breath. Dry cough. Interstitial lung disease. Kidney involvement can cause. Kidney disease. Protein in urine. Kidney dysfunction. Thyroid involvement occurs. Hypothyroidism from thyroiditis. Elevated thyroid antibodies. Thyroid disease management necessary. Lymph node enlargement may develop. Lymphadenopathy. Hepatosplenomegaly with liver and spleen enlargement. Depression and mood changes occur. The chronic disease and systemic symptoms affect mood. Anxiety about disease progression. The symptoms develop gradually and may be overlooked initially. Many people are diagnosed only after years of symptoms.

How is Sjögren’s Syndrome Detected and Diagnosed?

Sjögren’s Syndrome is diagnosed through a combination of clinical findings and specific laboratory and diagnostic tests. Early diagnosis is important for preventing complications. Clinical history of dry mouth and dry eyes. Symptoms present for at least three months. Impact on quality of life. Difficulty with eating or speaking. Eye discomfort. Systemic symptoms suggesting autoimmune disease. Family history of Sjögren’s or other autoimmune diseases. Physical examination reveals characteristic findings. Dry mucous membranes. Enlarged salivary glands. Evidence of oral candidiasis. Xerosis of mucous membranes. Raynaud’s phenomenon. Rashes. Other systemic findings. Schirmer test measures tear production. Paper strips placed under eyelids. The amount of wetting measured after five minutes. Low wetting indicates reduced tear production. Schirmer test supports diagnosis if abnormal. Ocular staining score uses vital dyes. Rose Bengal or lissamine green dyes. Dyes bind to damaged surface cells. Staining pattern indicates epithelial damage. Positive staining supports diagnosis. Salivary flow rate measurement. Timed collection of saliva. Low salivary flow rate indicates reduced production. Supports diagnosis if significantly decreased. Lip biopsy shows infiltration with lymphocytes. Salivary gland tissue shows inflammation. Lymphocyte infiltration is characteristic. Biopsy is definitive test. Biopsy can be done without major surgery. Rheumatoid Factor testing. Positive in about sixty percent of Sjögren’s. Antinuclear Antibody testing. Positive in about fifty percent. Anti-Ro and Anti-La antibody testing. Anti-Ro positive in about sixty percent. Anti-La positive in about forty percent. Anti-La and Anti-Ro together highly specific. Presence of these antibodies supports diagnosis. Complement levels. Low complement suggests more active disease. Complete blood count may show cytopenias. Anemia. Leukopenia. Thrombocytopenia. These suggest systemic autoimmune disease. Metabolic panel assesses organ function. Liver function tests. Kidney function tests. Elevated liver or kidney markers suggest organ involvement. Thyroid function tests. Thyroiditis common. TSH abnormalities. Anti-thyroid antibodies. Pulmonary function testing if respiratory symptoms. Chest imaging. Kidney biopsy if kidney involvement suspected. Eye examination if vision symptoms. Diagnostic criteria require dry mouth and dry eyes with supporting evidence. Schirmer test abnormality. Ocular staining. Decreased salivary flow. Positive lip biopsy. Positive autoimmune antibodies. Autoimmune markers supporting diagnosis. Early diagnosis allows early treatment. Diagnostic delay is common because Sjögren’s is often not considered.

What Systemic Complications Do People with Sjögren’s Syndrome Face?

People with Sjögren’s Syndrome face complications beyond dryness from systemic inflammation affecting multiple organs. The complications depend on which organs are affected and disease severity. Lymphoma is the most serious complication. B cell lymphoma develops. Increased risk compared to general population. Non-Hodgkin lymphoma most common. Lymphoma risk increases with disease duration. Regular monitoring for lymphoma important. Symptoms suggesting lymphoma warrant urgent evaluation. Lymphoma risk increases with certain antibody patterns. Lung involvement causes progressive pulmonary complications. Interstitial lung disease. Pulmonary fibrosis. Progressive scarring of lung tissue. Shortness of breath. Reduced pulmonary function. Respiratory failure in severe cases. Lung complications serious. Pulmonary function testing surveillance important. Kidney involvement causes kidney disease. Tubulointerstitial nephritis. Glomerulonephritis. Kidney dysfunction. Protein in urine. Kidney failure if severe. Regular kidney function monitoring essential. Neurological complications can cause serious disability. Peripheral neuropathy. Numbness and tingling. Sensory loss and pain. Cognitive dysfunction. Memory loss. Mental slowness. Difficulty concentrating. Central nervous system involvement. Transverse myelitis. Optic neuritis. Encephalitis. Seizures. Neurological damage can be permanent. Thyroid disease from thyroiditis. Hypothyroidism. Reduced thyroid hormone. Fatigue and weight gain from low thyroid hormone. Thyroid hormone replacement necessary. Autoimmune thyroiditis. Anti-thyroid antibodies. Cardiovascular involvement occurs. Vasculitis affecting blood vessels. Myocarditis affecting heart muscle. Pericarditis affecting pericardium. Cardiac arrhythmias. Increased cardiovascular disease risk. Dental disease from severe dryness. Rapid tooth decay. Multiple cavities. Tooth loss. Expensive dental restoration. Dental function compromised. Oral infections from reduced antimicrobial saliva. Fungal infections common. Bacterial infections. Oral pain and dysfunction. Vaginal dryness in women. Dyspareunia or pain with intercourse. Sexual dysfunction. Quality of life affected. Dryness of other mucous membranes. Respiratory tract dryness. Gastrointestinal tract dryness. Other mucosal sites. Systemic symptoms from chronic inflammation. Profound fatigue. Chronic pain. Reduced quality of life. Depression and psychological impact from chronic disease. Depression common. Anxiety. Grief about limitations. Mental health support important. Without treatment, complications can be serious. With appropriate treatment, complications can be prevented or reduced.

What Treatments Help People with Sjögren’s Syndrome?

Treatment for Sjögren’s Syndrome aims to manage dryness symptoms, suppress autoimmune inflammation, and prevent organ damage. There is no cure, but symptoms can be effectively managed. Artificial tears treat dry eyes. Frequent eye drops throughout day. Preservative-free eye drops reduce irritation. Lubricating eye ointments for nighttime. Gel products for extended lubrication. Regular eye care prevents corneal damage. Punctal plugs block tear drainage. Silicone plugs inserted in tear ducts. Slows tear loss. Improves eye moisture. Cyclosporine eye drops suppress inflammation. Topical cyclosporine reduces inflammation of lacrimal glands. Improves tear production. Restasis is FDA-approved cyclosporine product. Takes weeks to show effect. Lifitegrast eye drops reduce inflammation. FDA-approved for dry eye disease. Another option for eye treatment. Artificial saliva treats dry mouth. Saliva substitutes provide lubrication. Frequent use throughout day. Moisturizing mouth rinses. Saliva stimulants encourage natural saliva production. Pilocarpine orally stimulates saliva glands. Cevimeline stimulates saliva production. Tablets taken three times daily. Takes weeks to become effective. Sugar-free gum chewing stimulates saliva. Frequent small sips of water. Frequent mouth rinses. Oral moisturizers. Systematic oral hygiene prevents dental disease. Frequent brushing. Fluoride toothpaste. Regular dental care. Preventive fluoride treatments. Antifungal therapy treats oral candidiasis. Topical antifungal rinses. Oral antifungal medications. Systemic immunosuppressive therapy treats systemic disease. Hydroxychloroquine suppresses immune activation. Long-term hydroxychloroquine used for systemic features. Improves systemic symptoms. Improves fatigue. Improves joint pain. Corticosteroids suppress inflammation. Low-dose corticosteroids used for systemic features. Short-term high-dose for severe flares. Long-term use avoided due to side effects. Methotrexate suppresses immune function. Used for systemic disease. Reduces autoimmune antibodies. Helps systemic symptoms. Requires monitoring for toxicity. Mycophenolate mofetil suppresses lymphocyte proliferation. Used for systemic disease. Helps lung and kidney involvement. Azathioprine suppresses immune activation. Alternative immunosuppressive agent. Rituximab targets B cells. Rituximab used for severe systemic disease. Reduces B cell numbers. Reduces autoimmune antibody production. Used for lung, kidney, neurological involvement. Shows promise for Sjögren’s. TNF inhibitors may help systemic features. Some benefit reported in studies. Lymphoma risk consideration. Treatment must be individualized. Eye-specific therapy. Mouth-specific therapy. Systemic therapy if organ involvement. Combination therapy often used. Regular monitoring essential. Periodic assessments evaluate disease activity. Inflammatory markers. Organ function testing. Imaging as needed. Treatment adjusted based on response. With appropriate treatment, quality of life can be substantially improved despite chronic nature of disease.

Living with Sjögren’s Syndrome

Living with Sjögren’s Syndrome requires ongoing symptom management, treatment adherence, and adjustment to a chronic autoimmune disease. For people newly diagnosed with Sjögren’s Syndrome, the diagnosis can be overwhelming. Learning about a chronic autoimmune disease affecting multiple organs is frightening. However, understanding that symptoms can be managed and complications can be prevented offers hope. Patient education about Sjögren’s, treatment options, and disease course helps people understand their condition. Understanding that systemic treatment can prevent complications is important. Eye care requires daily attention. Regular eye drop use. Avoiding dry environments. Wearing protective eyewear in windy conditions. Computer work alternated with eye rest. Regular eye examinations. Prompt treatment of eye infections. Preventing corneal damage from dryness. Oral care requires meticulous attention. Frequent brushing. Daily flossing. Regular dental care. Preventive fluoride treatments. Antifungal treatment of oral thrush. Frequent mouth moisturizing. Adequate nutrition despite difficulty eating. Soft foods may be easier. Frequent small meals. Sipping water with meals. Adequate moisture in food. Nutritional supplements if needed. Work adjustments may become necessary. Frequent eye break from screen work. Frequent water and mouth moisturizing breaks. Environmental control of workplace humidity. Some people need flexible schedules. Fatigue may limit work capacity. Some people require part-time work. Disability support may become necessary. School adjustments help school-age people. Frequent water and eye care breaks. Educational accommodations. Extra time for physical education. Counselor support. Dating and relationships affected. Dry mouth affects kissing and intimacy. Dry eyes affect appearance. Communication about condition helps partners understand. Sexual dysfunction from vaginal dryness. Lubricating products help. Open communication important. Pregnancy possible but requires planning. Disease activity may change during pregnancy. Some treatments safe, others not. Regular medical monitoring necessary. Eye care continues throughout pregnancy. Medication management continues. Activity management. Pacing prevents fatigue exacerbation. Rest periods important. Stress management reduces flares. Stress appears to trigger Sjögren’s flares. Meditation and relaxation help. Counseling helps manage stress. Mental health care addresses psychological impact. Depression common. Anxiety about disease progression. Grief about limitations. Support groups help. Counseling helps. Antidepressants may be necessary. Social support important. Family understanding of disease. Friends and community engagement. Support groups for Sjögren’s patients. Online communities. Nutrition management. Soft foods easier to swallow. Adequate hydration important. Nutritional supplements if needed. Regular teeth care. Dental visits more frequent. Preventive care crucial. Fluoride treatments. Antifungal treatments as needed. Monitoring for complications. Regular kidney function checks. Thyroid function monitoring. Lung function testing if respiratory symptoms. Neurological assessment if neurological symptoms. Lymphoma surveillance. Ophthalmology follow-up. With appropriate treatment managing dryness symptoms, systemic immunosuppressive therapy preventing organ damage, regular monitoring for complications, symptom management, activity modification within limitations, stress management, mental health support, family and social support, most people with Sjögren’s Syndrome can manage symptoms effectively and prevent complications despite the chronic and potentially systemic nature of this autoimmune disease.

Frequently Asked Questions About Sjögren’s Syndrome

FAQ 1: Is Sjögren’s Syndrome hereditary? Sjögren’s Syndrome has a genetic component. If you have a family member with Sjögren’s or other autoimmune diseases, your risk is higher. However, genetics alone do not cause Sjögren’s. Environmental triggers are necessary. Most people with genetic predisposition do not develop Sjögren’s. Identical twins do not always both develop Sjögren’s. This shows genetics alone do not cause disease. Family members should be aware of increased risk and alert to symptoms.

FAQ 2: Can Sjögren’s Syndrome be cured? Sjögren’s Syndrome cannot be completely cured with current treatments. The underlying autoimmune process cannot be reversed. However, Sjögren’s can be very effectively managed. Symptoms can be controlled. Disease progression can be slowed. Organ damage can be prevented. Many people with appropriately treated Sjögren’s have minimal symptoms and good quality of life. Treatment is lifelong but highly effective.

FAQ 3: Does Sjögren’s Syndrome shorten life expectancy? Sjögren’s Syndrome does not necessarily shorten life expectancy. Most people with Sjögren’s have normal or near-normal life expectancy. Serious complications including lymphoma can affect longevity. However, appropriate monitoring and treatment reduce complication risk. Lung and kidney involvement can affect longevity if severe. With appropriate medical care, most Sjögren’s patients live full lifespans.

FAQ 4: Is Sjögren’s Syndrome just a cosmetic problem from dryness? No, Sjögren’s Syndrome is much more than a cosmetic problem. The dryness affects quality of life significantly. Systemic autoimmune inflammation affects multiple organs. Lung involvement can cause pulmonary fibrosis. Kidney involvement can cause kidney failure. Neurological involvement can cause serious neurological complications. Lymphoma risk is increased. Understanding Sjögren’s as a systemic autoimmune disease is important for appropriate management.

FAQ 5: Are there new treatments being developed for Sjögren’s Syndrome? Yes, there is ongoing research into improved Sjögren’s treatments. Interferon therapies showing promise. JAK inhibitors are being studied. Better understanding of B cell role leading to new B cell targeted therapies. Gene therapy approaches are being researched. Clinical trials of new medications continue. As new treatments are developed, outcomes will continue to improve.

References and Further Reading

For more information about Sjögren’s Syndrome, you can visit several trusted and authoritative sources that provide detailed information for patients and families dealing with this chronic autoimmune disease. The World Health Organization at WHO.int provides comprehensive information about autoimmune diseases including Sjögren’s Syndrome. The Sjögren’s Foundation at SjogrensFoundation.org offers excellent patient education, family resources, support communities, information about treatments and research, and updates about developments in Sjögren’s care. The American College of Rheumatology at Rheumatology.org provides resources for rheumatic diseases including Sjögren’s Syndrome. MedlinePlus, a service of the National Library of Medicine at MedlinePlus.gov, has detailed medical information about Sjögren’s Syndrome written in language that patients and families can easily understand without specialized medical knowledge. The National Institutes of Health at NIH.gov provides scientific information about Sjögren’s research, ongoing clinical trials, and the latest discoveries about Sjögren’s pathophysiology and treatment. The five main reference links are: 1) WHO.int – Autoimmune Diseases, 2) Sjögren’s Foundation, 3) American College of Rheumatology, 4) MedlinePlus – Sjögren’s Syndrome, and 5) National Institutes of Health.


Disclaimer

This article adapts publicly available information from WHO’s Sjögren’s Syndrome and autoimmune disease information pages. This content is for informational and educational purposes only and does not constitute medical advice. ObserverVoice.com is a news and information platform — not a healthcare provider. If you or someone you know has been diagnosed with Sjögren’s Syndrome or shows signs of this condition including dry eyes and dry mouth persisting for more than three months, ocular dryness, difficulty swallowing, oral candidiasis, joint pain, fatigue, or other systemic symptoms, please consult immediately with qualified healthcare professionals, rheumatologists, and Sjögren’s specialists for proper diagnostic evaluation with Schirmer testing, ocular staining, salivary flow testing, lip biopsy, and autoimmune antibody testing, and appropriate treatment planning with eye care, mouth care, and systemic immunosuppressive therapy as needed. Early diagnosis and appropriate treatment significantly improve quality of life and prevent systemic complications. For more information, visit WHO.int and ObserverVoice.com.


Observer Voice is the one stop site for National, International news, Sports, Editor’s Choice, Art/culture contents, Quotes and much more. We also cover historical contents. Historical contents includes World History, Indian History, and what happened today. The website also covers Entertainment across the India and World.

Follow Us on Twitter, Instagram, Facebook, & LinkedIn

Shreya Suri

Social Media Manager at Observer Voice, handling health content publishing and digital engagement across platforms.
Back to top button